Pro Nephro AKI (NGAL) is now FDA-Cleared     READ MORE

Mouse monoclonal antibody

Anti-Vasoactive Intestinal Peptide (human, bovine, porcine, rat, VIP)

CAT NO: ABS 023-02 | Application: ELISA, WB, IHC, IF


Cat. No.

ABS 023-02

Specificity

ABS 023-02 binds to human, bovine, porcine or rat VIP, but does not bind to PHM or PACAP.

Immunogen

Vasoactive intestinal peptide

Host

Mouse

Positive Species Reactivity

Human, Bovine, Pig, Rat

Negative Species Reactivity

Not determined

Isotype

IgG1/k

Gene ID

7432

Clone Number

2

Epitope Specificity

Not determined

Unit Size

400 µL: Cat. No. ABS 023-02-04 1 mL: Cat. No. ABS 023-02-1 1 mg/mL +/- 15%. See Certificate of Analysis for details.

Purification

Protein A/G purified (from culture supernatant)

Form

Liquid

Solvent

0.01 M phosphate buffer, pH 7.4, containing 0.5 M NaCl and 15 mM sodium azide

Conjugation

Unconjugated BSA free

Storage

4-8ºC without exposure to light. No precautions necessary during handling.

Target

Vasoactive intestinal peptide (VIP) is a 28 amino acid peptide belonging to the secretin-glucagon family of peptide hormones. Its sequence is identical in humans, cows, pigs and rats. VIP is widely distributed in the central and peripheral nervous systems, acting as a neurotransmitter or neuromodulator. Peripherally it is involved in vaso- and bronchodilatation, smooth muscle relaxation and stimulation of secretion. Ectopic endocrine tumors secreting VIP (VIPomas) give rise to raised plasma levels of VIP and are associated with watery diarrhea, hypokalemia and achlorhydria syndrome. VIP shows high sequence homology with peptide histidine-methionine (PHM) in humans or peptide histidine-serine (PHI) in pigs or rats, present in the same precursor, and with the neuropeptide pituitary adenylate cyclase activating polypeptide (PACAP).